Lochner Daniel
Chief Financial Officer
Lochner Daniel has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Mar 5, 2026.
On the most recent filing, Lochner Daniel is listed as Chief Financial Officer at Tectonic Therapeutic, Inc. Inside the rolling window, Lochner Daniel reported 1 open-market purchase totaling $130K in TECX and no open-market sales.
Companies traded
Other insiders at TECX
Insider Buying
$130K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lochner Daniel made?
Lochner Daniel has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Lochner Daniel trade?
Lochner Daniel has filed SEC Form 4 disclosures for 1 company, including TECX.
When was Lochner Daniel's most recent SEC Form 4 filing?
Lochner Daniel's most recent SEC Form 4 filing on Tracefour is dated Mar 5, 2026.
What is Lochner Daniel's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lochner Daniel is listed as Chief Financial Officer.
What is Lochner Daniel's total buy and sell value in the current window?
Inside the rolling retention window, Lochner Daniel bought $130K and sold $0 based on SEC Form 4 filings.
What was Lochner Daniel's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 6,000 TECX shares on 2026-02-10, worth $130K, per SEC Form 4 filings.